Post by Icon Group

Global leaders in stereotactic radiosurgery and radiotherapy came together at the recent International Stereotactic Radiosurgery Society (ISRS) Congress.   Held in Sydney, Australia and sponsored by Icon Cancer Centre - Australia & New Zealand, the 2026 Congress focused on sharing insights and exploring what’s next for precision cancer care. From evolving clinical approaches and emerging technologies, the sessions reinforced the importance of collaboration in translating innovation into real-world impact.   Congratulations to our Icon Cancer Centre radiation oncologists Dr Cecelia Gzell (Chair of the Local Organising Committee and ISRS Treasurer), A/Prof Matthew Foote and Prof Shankar Siva (Scientific Committee Co-chairs) for organising such a successful and meaningful forum.   We also recognise all our Icon Cancer Centre attendees who presented and contributed their ideas in addressing the global cancer burden and how to further improve patient health outcomes. With 100% stereotactic capability across our network, Icon Group’s ensuring patients have access to highly targeted treatment options, closer to home. Read more about our capabilities and the future of stereotactic radiotherapy in this recent thought leadership piece by A/Prof Foote: https://lnkd.in/gKcVrmpS #ISRS2026 #RadiationOncology #Radiosurgery #CancerCare #Innovation